Fibromyalgia: A critical digest of the recent literature

Clinical and Experimental Rheumatology

Volumn 29, Issue 6 SUPPL. 69, 2011, Pages

  Bazzichi, L ^a   Sernissi, F ^a   Consensi, A ^a   Giacomelli, C ^a   Sarzi Puttini, P ^b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Assessment; Fibromyalgia; Pathogenesis; Treatment

Indexed keywords

AMITRIPTYLINE; CYCLOBENZAPRINE; DOLASETRON MESILATE; DULOXETINE; FLUOXETINE; MELATONIN; MILNACIPRAN; NORTRIPTYLINE; OPIATE; OXYBATE SODIUM; PLACEBO; PREGABALIN;

ALLODYNIA; CLINICAL ASSESSMENT; CONSTIPATION; COST BENEFIT ANALYSIS; DISEASE ACTIVITY; DIZZINESS; DRUG SAFETY; FATIGUE; FIBROMYALGIA; GENETIC ASSOCIATION; HEADACHE; HUMAN; HYPERALGESIA; IMMUNE SYSTEM; INFLAMMATION; MEDLINE; MUSCLE CRAMP; MUSCLE STIFFNESS; NAUSEA; PAIN; PHYSIOTHERAPY; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SOMNOLENCE; STRESS; WHOLE BODY VIBRATION; ANIMAL; CHRONIC FATIGUE SYNDROME; CHRONIC PAIN; COGNITIVE DEFECT; DISEASE MODEL; MOOD DISORDER; SYNDROME;

ANIMALS; CHRONIC PAIN; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; FATIGUE SYNDROME, CHRONIC; FIBROMYALGIA; HUMANS; MOOD DISORDERS; PUBMED; SYNDROME;

EID: 84858820951     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. KINDLER LL, BENNETT RM, JONES KD: Central sensitivity syndromes: mounting pathophysiologic evidence to link fibromyalgia with other common chronic pain disorders. Pain Manag Nurs 2011;12:15-24.
2. PETERSEL DL, DROR V, CHEUNG R: Central amplification and fibromyalgia: disorder of pain processing. J Neurosci Res 2011;89:29-34.
3. HARRIS RE: Elevated excitatory neurotransmitter levels in the fibromyalgia brain. Arthritis Res Ther 2010;12:141.
4. REYES DEL PASO GA, GARRIDO S, PULGAR Á, DUSCHEK S: Autonomic cardiovascular control and responses to experimental pain stimulation in fibromyalgia syndrome. J Psychosom Res 2011;70:125-34.
5. NORMAND E, POTVIN S, GAUMOND I, CLOUTIER G, CORBIN JF, MARCHAND S: Pain inhibition is deficient in chronic widespread pain but normal in major depressive disorder. J Clin Psychiatry 2011;72:219-24.
6. LAMBIN DI, THIBAULT P, SIMMONDS M, LARIVIERE C, SULLIVAN MJ: Repetition-induced activity-related summation of pain in patients with fibromyalgia. Pain 2011;152:1424-30.
7. ALONSO-BLANCO C, FERNÁNDEZ-DE-LAS-PEÑAS C, MORALES-CABEZAS M, ZARCO-MORENO P, GE HY, FLOREZ-GARCÍA M: Multiple active myofascial trigger points reproduce the overall spontaneous pain pattern in women with fibromyalgia and are related to widespread mechanical hypersensitivity. J Clin Pain 2011;27:405-13.
8. KOROSCHETZ J, REHM SE, GOCKEL U et al.: Fibromyalgia and neuropathic pain-differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia. BMC Neurol 2011;11:55.
9. HOLLINS M, HARPER D, MAIXNER W: Changes in pain from a repetitive thermal stimulus: the roles of adaptation and sensitization. Pain 2011;152:1583-90.
10. STAUD R: Is it all central sensitization? Role of peripheral tissue nociception in chronic musculoskeletal pain. Curr Rheumatol Rep 2010;12:448-54.
11. BUSKILA D, ABLIN JN, BEN-ZION I et al.: A painful train of events: increased prevalence of fibromyalgia in survivors of a major train crash. Clin Exp Rheumatol 2009;27(Suppl. 56):S79-85.
12. GREEN PG, ALVAREZ P, GEAR RW, MENDOZA D, LEVINE JD: Further validation of a model of fibromyalgia syndrome in the rat. J Pain 2011;12:811-8.
13. WILBARGER JL, COOK DB: Multisensory hypersensitivity in women with fibromyalgia: implications for well being and intervention. Arch Phys Med Rehabil 2011;92:653-6.
14. DI FRANCO, IANNUCCELLI C, ALESSAN-DRINI C et al.: Autonomic dysfunction and neuropeptide Y in fibromyalgia. Clin Exp Rheumatol 2009;27(Suppl. 56):S75-8.
15. XIAO Y, HE W, RUSSELL IJ: Genetic polymorphisms of the beta2-adrenergic receptor relate to guanosine protein-coupled stimulator receptor dysfunction in fibromyalgia syndrome. J Rheumatol 2011;38:1095-103.
16. BAZZICHI L, ROSSI A, GIACOMELLI C, BOM-BARDIERI S: Exploring the abyss of fibromyalgia biomarkers. Clin Exp Rheumatol 2010;28(Suppl. 63):S125-30.
17. COHEN H, NEUMANN L, GLAZER Y, EBSTEIN RP, BUSKILA D: The relationship between a common catechol-O-methyltransferase (COMT) polymorhism val (158) met and fibromyalgia. Clin Exp Rheumatol 2009;27(Suppl. 56):S51-6.
18. BLANCO I, BÉRITZE N, ARGÜELLES M et al.: Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin Rheumatol 2010;29:1403-12.
19. ABLIN JN, BAR-SHIRA A, YARON M, ORRURTREGER A: Candidate-gene approach in fibromyalgia syndrome: association analysis of the genes encoding substance P receptor, dopamine transporter and alpha 1-antitrypsin. Clin Exp Rheumatol 2009;27(Suppl. 56):S33-8.
20. SMITH SB, MAIXNER DW, FILLINGIM RB et al.: Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. Arthritis Rheum 2011 Sep. 8 [Epub].
21. GIACOMELLI C, BAZZICHI L, GIUSTI L et al.: MALDI-TOF and SELDI-TOF analysis: "tandem" techniques to identify potential biomarker in fibromyalgia Reumatismo 2011;63:165-170.
22. AKAR S, CAN G, SOYSAL O et al.: Fibromyalgia syndrome in patients with rheumatoid arthritis: which criteria is appropriate to define the condition. Clin Exp Rheumatol 2009;27(Suppl. 56):S106.
23. TORRENTE-SEGARRA V, CARBONELL-ABELLÓ J, CASTRO-OREIRO S, MANRESA DOMÍNGUEZ JM: Association between fibromyalgia and psychiatric disorders in systemic lupus erythematosus. Clin Exp Rheumatol 2010;28(Suppl. 63):S22-6.
24. BAZZICHI L, ROSSI A, ZIRAFA C et al.: Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia? Rheumatol lnt 2010 Nov. 18 [Epub].
25. KIM SK, KIM KS, LEE YS, PARK SH, CHOE JY: Arterial stiffness and proinflammatory cytokines in fibromyalgia syndrome. Clin Exp Rheumatol 2010;28(Suppl. 63):S71-7.
26. WOLFE F, SMYTHE HA, YUNUS MB et al: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Connittee. Arthritis Rheum 1990;33:160-72. (Pubitemid 20098653)
27. WOLFE F, CLAWN D, FITZCHARLES MA et al.: The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity. Arthritis Care Res 2010;62:600-10.
28. WOLFE F, CLAUW DJ, FITZCHARLES MA et al.: Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 2011;38:1113-22.
29. PRIORI R, IANNUCCELLI C, ALESSANDRI C, et al.: Fatigue in Sjögren's syndrome: relationship with fibromyalgia, clinical and biologic features. Clin Exp Rheumatol 2010;28(Suppl. 63):S82-6.
30. STUIFBERGEN AK, PHILLIPS L, CARTER P, MORRISON J, TODD A: Subjective and objective sleep difficulties in women with fibromyalgia syndrome. J Am Acad Nurse Pract 2010;22:548-56.
31. OKIFUJI A, HARE BD: Nightly analyses of subjective and objective (actigraphy) measures of sleep in fibromyalgia syndrome: what accounts for the discrepancy? Clin J Pain 2011;27:289-96.
32. JENKINS CD, STANTON BA, NIEMCRYK SJ, ROSE RM: A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 1988;41:313-21. (Pubitemid 18089231)
33. CRAWFORD BK, PIAULT EC, LAI C, SARZI-PUTTINI P: Assessing sleep in fibromyalgia: investigation of an alternative scoring method for the Jenkins Sleep Scale based on data from rendomised controlled stidies. Clin Exp Rheumatol 2010;28(Suppl. 63):S100-9.
34. OKIFUJI A, DONALDSON GW, BARCK L, FINE PG: Relationship between fibromyalgia and obesity in pain, function, mood, and sleep. J Pain 2010;11:1329-37.
35. VIOLA-SALTZMAN M, WATSON NF, BOGART A, GOLDBERG J, BUCHWALD D: High prevalence of restless legs syndrome among patients with fibromyalgia: a controlled crosssectional study. J Clin Sleep Med 2010 15;6:423-7.
36. BAZZICHI L, CONSENSI A, ROSSI A et al.: Spasmophilia comorbidity in fibromyalgia syndrome. Clin Exp Rheumatol 2010;28(Suppl. 63):S94-9.
37. BHATTY SA, SHAIKH NA, IRFAN M, KASHIF SM, VASWANI AS, SUMBHAI A, GUNPAT: Vitamin D deficiency in fibromyalgia. J Pak Med Assoc 2010;60:949-51.
38. HEIDARI B, SHIRVANI JS, FIROUZJAHI A, HEIDARI P, HAJIAN-TILAKI KO: Association between nonspecific skeletal pain and vitamin D deficiency. Int J Rheum Dis 2010;13:340-6.
39. DE REZENDE PENA C, GRILLO LP, DAS CHAGAS MEDEIROS MM: Evaluation of 25-hydroxyvitamin D serum levels in patients with fibromyalgia. J Clin Rheumatol 2010;16:365-9.
40. GLAZER Y, CHOEN H, BUSKILA D, EBSTEIN RP, GLOSTER L, NEUMANN L: Are psychological distress symptoms different in fibromyalgia patients compared to relatives with and without fibromyalgia? Clin Exp Rheumatol 2009;27(Suppl. 56):S11-S15.
41. GLAZER Y, BUSKILA D, COHEN H, EBSTEIN RP, NEUMANN L: Differences in the personality profile of fibromyalgia patients and their relatives with and without fibromyalgia. Clin Exp Rheumatol 2010;28(Suppl. 63):S27-32.
42. DELL'OSSO L, BAZZICHI L, CONSOLI G et al.: Manic spectrum symptoms are correlated to the severity of pain and the health-related quality of life in patients with fibromyalgia. Clin Exp Rheumatol 2009;27(Suppl. 56):S57-61.
43. WOLFE F, HASSETT AL, WALITT B, MICHAUD K: Mortality in fibromyalgia: a study of 8, 186 patients over thirty-five years. Arthritis Care Res 2011;63:94-101.
44. DREYER L, KENDALL S, DANNESKIOLD-SAMSØE B, BARTELS EM, BLIDDAL H: Mortality in a cohort of Danish patients with fibromyalgia: increased frequency of suicide. Arthritis Rheum 2010;62:3101-8.
45. RIVERA J, REJAS J, ESTEVE-VIVES J; GROUPO ICAF: Resource utilisation and health care costs in patients diagnosed with fibromyalgia in Spain. Clin Exp Rheumatol 2009;27(Suppl. 56):S39-45.
46. WINKELMANN A, PERROT S, SCHAEFER C et al.: Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study. Appl Health Econ Health Policy 2011;9:125-36.
47. MALMUD CJ: Focus on pain mechanisms and pharmacotherapy in the treatment of fibromyalgia syndrome. Clin Exp Rheumatol. 2009;27(Suppl. 56):S86-91.
48. MITSIKOSTAS DD, CHALARAKIS NG, MANTONAKIS LI, DELICHA EM, SFIKAKIS PP: Nocebo in fibromyalgia: meta-analysis of placebo-controlled clinical trials and implications for practice. Eur J Neurol 2011 Oct. 4 [Epub].
49. ARNOLD LM, WILLIAMS DA, HUDSON JI et al.: Development of responder definitions for fibromyalgia clinical trials. Arthritis Rheum 2011 Sep. 27 [Epub].
50. KULSHRESHTHA P, GUPTA R, YADAV RK, BIJLANI RL, DEEPAK KK: Effect of low-dose amitriptyline on autonomic functions and peripheral blood flow in fibromyalgia: a pilot study. Pain Med 2011 Dec. 5 [Epub].
51. SMITH B, PETERSON K, FU R, MCDONAGH M. THAKURTA S, PORTLAND OR: Drug Class Reviews. Oregon Health & Science University, 2011.
52. MOLDOFSKY H, HARRIS HW, ARCHAMBAULT WT, KW ONG T, LEDERMAN S: Placebo-controlled Study. J Rheumatol 2011;38:2653-63.
53. FITZCHARLES MA, STE-MARIE PA, GAMSA A, WARE MA, SHIR Y: Opioid use, misuse, and abuse in patients labeled as fibromyalgia Am J Med 2011;124:955-60.
54. DEPOORTERE R, MELEINE M, BARDIN L et al.: Milnacipran is active in models of irritable bowel syndrome and abdominal visceral pain in rodents. Eur J Pharmacol 2011;672:83-7.
55. MEASE PJ, ZIMETBAUM PJ, DUH MS et al.: Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data (February). Ann Pharmacother 2011 Feb. 8 [Epub].
56. ARNOLD LM, CLAUW D, WANG F, AHL J, GAYNOR PJ, WOHLREICH MM: Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. J Rheumatol 2010;37:2578-86.
57. KNADLER MP, LOBO E, CHAPPELL J, BERGSTROM R: Duloxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet 2011;50:281-94.
58. WANG F, RUBERG SJ, GAYNOR PJ, HEINLOTH AN, ARNOLD LM: Early improvement in pain predicts pain response at endpoint in patients with fibromyalgia. J Pain 2011;12:1088-94.
59. ARNOLD LM, WANG F, AHL J, GAYNOR PJ, WOHLREICH MM: Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial. Arthritis Res Titer 2011;13:R86.
60. TZELLOS TG, TOULIS KA, GOULIS DG et al.: Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic reviewand a meta-analysis. J Clin Pharm Ther 2010;35:639-56.
61. PAUER L, WINKELMANN A, ARSENAULT P et al.: An International, Randomized, Double-blind, Placebo-controlled, Phase III Trial of Pregabalin Monotherapy in Treatment of Patients with Fibromyalgia. J Rheumatol 2011;38:2643-52.
62. CHOY E, MARSHALL D, GABRIEL ZL, MITCHELL SA, GYLEE E, DAKIN HA: A systematic review and mixed treatment comparison of the efficacy of pharmacological treatments for fibromyalgia. Semin Arthritis Rheum 2011;41:335-45.
63. BHADRA P, PETERSEL D: Medical conditions in fibromyalgia patients and their relationship to pregabalin efficacy: pooled analysis of Phase III clinical trials. Expert Opin Pharmacother 2010;11:2805-12.
64. RUSSELL IJ, HOLMAN AJ, SWICK TJ et al:. Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study. 2011;152:1007-17.
65. STAUD R: Sodium oxybate for the treatment of fibromyalgia. Expert Opin Pharmacother 2011;12:1789-98.
66. VERGNE-SALLE P, DUFAURET-LOMBARD C et al.: A randomised, double-blind, placebocontrolled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia. Eur J Pain 2011;15:509-14.
67. HUSSAIN SA, AL-KHALIFA II, JASIM NA, GORIAL FI: Adjuvant use of melatonin for treatment of fibromyalgia. J Pineal Res 2011;50:267-71.
68. SUMAN AL, BIAGI B, BIASI G et al.: Oneyear efficacy of a 3-week intensive multidisciplinary non-pharmacological treatment program for fibromyalgia patients. Clin Exp Rheumatol 2009;27:7-14.
69. CAZZOLA M, ATZENI F, SALAFFI F, STISI S, CASSISI G, SARZI-PUTTINI P: Which kind of exercise is best in fibromyalgia therapeutic programmes? A practical review Clin Exp Rheumatol 2010;28(Suppl. 63):SI 17-24.
70. SANUDO B, DE HOYO M, CARRASCO L et al.: The effect of 6-week exercise programme and whole body vibration on strength and quality of life in women with fibromyalgia: a randomised study. Clin Exp Rheumatol 2010;28(Suppl. 63):S40-5.
71. VAS J, MODESTO M, AGUILAR I, SANTOS-REY K, BENÍTEZ-PAREJO N, RIVAS-RUIZ F: Effects of acupuncture on patients with fibromyalgia: study protocol of a multicentre randomized controlled trial. Trials 2011;12:59.
72. LANGHORST J, KLOSE P, MUSIAL F, IRNICH D, HAUSER W: Efficacy of acupuncture in fibromyalgia syndrome - a systematic review with a meta-analysis of controlled clinical trials. Rheumatology 2010;49:778-88.
73. DI FRANCO M, IANNUCCELLI C, ATZENI F et al.: Pharmacological treatment of fibromyalgia. Clin Exp Rheumatol 2010;28(Suppl. 63):SI 10-6.
74. SALAFFI F, SARZI-PUTTINI P, GIROLIMETTI R, ATZENI F, GASPARINI S, GRASSI W: Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clin Exp Rheumatol 2009;27(Suppl. 56):S67-74.
75. SALAFFI F, SARZI-PUTTINI P, CIAPETTI A, ATZENI F: Assessment instruments for patients with fibromyalgia: properties, applications and interpretation. Clin Exp Rheumatol 2009;27(Suppl 56):S92-105.